BioGaia AB Interim report (1 January - 30 September 2013)

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Oct 23, 2013 at 2:15 AM

President’s comments: “As I have pointed out before, we monitor our own performance based on the rolling 12-month figures. Sales of finished consumer products grew by 12%, excluding foreign exchange effects, and component products fell by 25% (due to the Nestlé deal in 2012). But we are aiming higher. In view of the development in most of the countries where we are active and the new product launches we are planning, we have no intention of changing this ambition,” says Peter Rothschild, President of BioGaia. Period from 1 January to 30 September 2013 (Figures in brackets refer to the same period of last year) · Net sales reached SEK 225.7 million (216.8¹), an increase of SEK 8.9 million (4%). Excluding foreign exchange effects, net sales improved by 7%. · Net sales of finished consumer products amounted to SEK 181.1 million (172.0), representing growth of SEK 9.1 million (5%). Excluding foreign exchange effects, net sales improved by 9%. · Net sales of component products amounted to SEK 43.6 million (43.8¹), a decrease of SEK 0.2 million (0.5%). Excluding foreign exchange effects, net sales rose by 1%. · Operating profit was SEK 57.9 million (58.9¹), down by SEK 1.0 million (2%). Excluding foreign exchange effects, operating profit improved by 2%. · Profit after tax was SEK 47.9 million (51.7¹), a decrease of SEK 3.8 million (7%). · Earnings per share totalled SEK 2.63 (2.88¹). · The period’s total cash flow was SEK -131.7 million (233.3). Last year’s cash flow included payment of SEK 356.0 million in licence revenue from Nestlé. Cash and cash equivalents at 30 September 2013 totalled SEK 243.2 million (404.1). Cash flow since 30 September 2012 includes dividends of SEK 172.7 million, tax payments of SEK 37.7 million, equipment investments in TwoPac of SEK 13.3 million and the acquisition of shares in TwoPac of SEK 30.0 million. Third quarter of 2013 · Net sales amounted to SEK 62.2 million (62.8), down by SEK 0.6 million (1%). There were no material foreign exchange effects on sales in the quarter. · Net sales of finished consumer products totalled SEK 46.4 million (50.2), a decrease of SEK 3.8 million (8%). · Net sales of component products amounted to SEK 15.7 million (12.5), an improvement of SEK 3.2 million (26%). · Operating profit was SEK 13.8 million (13.5), an increase of SEK 0.3 million (2%). Excluding foreign exchange effects, operating profit decreased by 3%. · Profit after tax was SEK 13.4 million (14.2), a decrease of SEK 0.8 million (6%). Key events in the third quarter of 2013 · BioGaia acquires remaining 50% of TwoPac. · FDA approves BioGaia’s request for orphan drug designation. · New study shows that Lactobacillus reuteri Prodentis improves treatment of patients with periodontal disease. Key events after the end of the third quarter · Meta-analysis regarding Lactobacillus reuteri Protectis and colic. 1) Excluding license revenue from Nestlé. Net sales and profit for the previous year also included license revenue of SEK 356.0 million from Nestlé for a perpetual license to use Lactobacillus reuteri Protectis in infant formula during the remaining term of the patent, which is regarded as non-recurring revenue. Including license revenue from Nestlé, net sales for the period January -September 2012 amounted to SEK 572.8 million, operating profit to SEK 414.9 million, profit after tax to SEK 314.1 million and earnings per share to SEK 18.07. Teleconference: You are welcome to take part in a teleconference on the interim report that will be held today at 9:30 a.m. by President Peter Rothschild. To participate in the conference, please see www.biogaia.com/agenda. BioGaia has published this information in accordance with the Swedish Securities Market Act. The information was issued for publication on 23 October 2013, 8:00 a.m. CET. This is a translation of Swedish version of the interim report. When in doubt, the Swedish wording prevails. Latest press releases from BioGaia: · 2013-10-10 Meta-analysis: Lactobacillus reuteri Protectis only probiotic effective in treating colic · 2013-08-22 BioGaia AB Interim report 1 January – 30 June 2013 · 2013-08-16 New study shows: Lactobacillus reuteri Prodentis improves periodontal treatment BioGaia AB Box 3242, SE-103 64 STOCKHOLM Street address: Kungsbroplan 3A, Stockholm Telephone: 46 8-555 293 00, Corp. Identity no. 556380-8723 www.biogaia.com For additional information contact: Peter Rothschild, President, BioGaia AB, telephone 46 8-555 293 00 or Margareta Hagman, Executive Vice President, BioGaia AB, telephone 46 8-555 293 00 BioGaia is a healthcare company that develops, markets and sells probiotic products with documented health benefits. The products are primarily based on the lactic acid bacterium Lactobacillus reuteri, which has probiotic, health -enhancing effects. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap list of the NASDAQ OMX Nordic Exchange Stockholm. www.biogaia.com

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

STRATA Showcases Excimer Laser Success in Dermatology

The Cutting Edge of Skin Care: STRATA's Spotlight It's not every day you hear about dermatology shaking things up, but STRATA Skin Sciences, Inc. pulled it off with flair at the 2026 Fall Clinical Dermatology Conference in Las Vegas. For 'skin in the game,' these folks are leading the charge with their innovative excimer laser phototherapy approach, shining a fresh light...

CellFiber Expands to Philly: Boosting US Biotech Scene

CellFiber's Leap into 'Cellicon Valley' Folks, when the biotech winds start blowing, you better have your sails up. CellFiber Co., Ltd., a Tokyo-based innovator, has landed itself a comfy spot in the City of Brotherly Love. We're talking Philadelphia, folks, or, as it's dubbed in certain circles, 'Cellicon Valley.' Now if that's not a name that screams biotech pedigree, I...

Ingram Mercantile's Aviation Push: SCORE or Sink?

Unpacking Neobanx's Strategic Play Straight off the tarmac, Neobanx launches Ingram Mercantile, placing their bets on the aviation sector with none other than Eli Stepp at the helm. This ain't just another day in the sky for those in the know; it's part of a gutsy bid to inject some high-octane intelligence into the world of retail. I mean, have you seen the landscape...

Helio Genomics Shakes Up Liver Cancer Detection Strategy

Rethinking Liver Cancer Detection with HelioLiver Sometimes you stumble upon a tech piece that might genuinely shake up the game. Helio Genomics just poured some serious intel at the San Antonio Liver Cancer Symposium, showcasing how their HelioLiver Dx might outgun traditional scans in sniffing out hepatocellular carcinoma (HCC). They threw down four studies revealing...

ODL’s Impact Door System Wins 2026 Editors' Pick

Award-Winning Entry: ODL's Latest Triumph In a world where first impressions count, ODL, Inc. sure knows how to leave a mark. Their Impact Rated Fiberglass Entry System with Keystone Frame Technology snagged a notable spot in the 2026 Best of Products Awards by Architect's Newspaper. Let me tell you, in the building biz, accolades like these are no small potatoes. To get...

Moore, Schulman & Moore Attorneys Earn Top Honors Again

In the realm of family law, consistency in excellence matters just as much as landing a high-stakes stock trade. Moore, Schulman & Moore, APC, a San Diego family law outfit, has grabbed the spotlight yet again with nine of its ace attorneys snagging recognition from the 2027 Super Lawyers roster. A Tradition of Professional Recognition Leading the pack is Erik Moore, a...

Mastering Packaging Costs: Beyond the Box Price

Peeling Back the Layers of Packaging Costs Packaging's a bit like an onion—every layer you peel back reveals another cost you didn’t see at first glance. Folks in the know, like Kyle Reger of Jamestown Container Companies, are flipping the script on how we approach packaging expenses. It's not just about snagging the cheapest box on the shelf anymore. There's a whole...

India's Women Apparel Market Grows Amid Innovation

India's Women Apparel Market on the Rise The winds of fashion change are sweeping through India, and the women's apparel market is at the heart of this sartorial hurricane. Set to explode from USD 28,786.82 million in 2024 to USD 45,491.96 million by 2032, this market is turning heads with a compound annual growth rate (CAGR) of 5.21%. What's stirring this pot, you ask?...

NCICU's Digital Boost for NC Transfer Students

New Platform Eases the Transfer Struggle They’ve finally cooked up something good for the college crowd in North Carolina. The NCICU, with the NCCCS, has rolled out a platform called Transfer Pathways to simplify students' path from two-year to four-year schools. This ain't just a tweak—it's backed by a hefty $2 million in grants. Hats off to those...

Duke Energy Braces for Isaias: Key Prep Steps Ahead

Brace Yourself: Duke Energy Gears Up for Isaias In the ever-unpredictable game of Mother Nature versus infrastructure, Duke Energy is stepping into the ring once more, readying to tackle potential outages across the Carolinas as Hurricane Isaias edges near. Listen, if there's one thing I've learned over years of watching these weather events unfold on the stock ticker and...